Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
grade B 111.61 0.13% 0.15
LLY closed up 0.13 percent on Thursday, August 22, 2019, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Flat
See historical LLY trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Support Bullish 0.13%
Crossed Above 50 DMA Bullish 0.13%
Fell Below 50 DMA Bearish 0.54%
180 Bearish Setup Bearish Swing Setup 0.54%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.54%

Older signals for LLY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Diabetes Pharmaceutical Products Neuroscience Schizophrenia Antibiotics Pulmonary Arterial Hypertension Psychiatry Animal Health Products Psychiatric Diagnosis Major Depressive Disorder Attention Deficit Hyperactivity Disorder Depression Wholesale Distributors Benign Prostatic Hyperplasia Obsessive Compulsive Disorder Osteoporosis Cardiovascular Products Bipolar Disorder Depressive Disorder Erectile Dysfunction Head And Neck Cancers Major Depressive Disorders Oncology Products Bulimia Nervosa High Cholesterol Psychology Respiratory And Other Diseases Testosterone Deficiency Treatment Resistant Depression
Is LLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 132.13
52 Week Low 103.655
Average Volume 3,842,173
200-Day Moving Average 116.6167
50-Day Moving Average 111.3756
20-Day Moving Average 111.17
10-Day Moving Average 112.064
Average True Range 2.5521
ADX 11.74
+DI 19.1008
-DI 20.8039
Chandelier Exit (Long, 3 ATRs ) 108.4837
Chandelier Exit (Short, 3 ATRs ) 114.6563
Upper Bollinger Band 115.1316
Lower Bollinger Band 107.2084
Percent B (%b) 0.56
BandWidth 7.127103
MACD Line 0.2062
MACD Signal Line 0.1664
MACD Histogram 0.0398
Fundamentals Value
Market Cap 117.75 Billion
Num Shares 1.05 Billion
EPS 2.31
Price-to-Earnings (P/E) Ratio 48.32
Price-to-Sales 4.03
Price-to-Book 6.30
PEG Ratio 1.77
Dividend 2.08
Dividend Yield 1.86%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 113.83
Resistance 3 (R3) 113.80 113.04 113.46
Resistance 2 (R2) 113.04 112.47 113.05 113.34
Resistance 1 (R1) 112.32 112.12 112.68 112.35 113.21
Pivot Point 111.56 111.56 111.74 111.57 111.56
Support 1 (S1) 110.84 110.99 111.20 110.87 110.01
Support 2 (S2) 110.08 110.64 110.09 109.88
Support 3 (S3) 109.36 110.08 109.76
Support 4 (S4) 109.39